Yuri Khodjamirian, CIO of Tema ETFs, joins physicians Jason Fung, Ken Berry, and Jesse Morse to discuss the future of U.S. healthcare. They explore the implications of Robert F. Kennedy Jr.'s policies, specifically focusing on disease prevention through diets like intermittent fasting. The panel debates drug reform's impact on pharma finance and advocates for RFK Jr.'s idea of radical transparency to combat misinformation. They also highlight the potential of deregulation in biotechnology, while emphasizing innovative investment opportunities related to obesity and cardiometabolic health.

CEOs and medical experts discuss the challenges of an aging population, including economic impact, preventive treatments, pension spending, and the impact on the economy. They emphasize the importance of proactive healthcare and investing in new technologies to address the needs of the aging population.